首页|海洋糖类化合物与阿尔茨海默病以及帕金森病研究进展

海洋糖类化合物与阿尔茨海默病以及帕金森病研究进展

扫码查看
阿尔茨海默病(AD)和帕金森病(PD)是退行性神经系统疾病中发病率最高的两类疾病.海洋糖类化合物因其具有多种生物活性,如抗氧化、抗凝血、抗肿瘤、降血脂、抗菌等,而受到越来越多的关注.目前,海洋糖类化合物在AD和PD中防治发挥作用的相关研究越来越多,本综述总结了海洋糖类化合物在AD和PD作用机制面的研究进展,以期为AD和PD的防治带来新的角度.
Research progress on the correlation between Marine carbohydrates and Alzheimer's disease and Parkinson's disease
Alzheimer's disease(AD)and Parkinson's disease(PD)are two of the most prevalent types of degenerative neurological diseases.The biological activities of marine glycoconjugates,such as antioxidant,anticoagulant,antitumor,hypolipidemic,and antibacterial properties,have gained significant attention.There is a growing body of research exploring the role of marine glycoconjugates in AD and PD.This review aims to summarize the recent progress in the use of marine glycoconjugates for the prevention and treatment of AD and PD,providing new insights for future approaches in managing these diseases.

Marine carbohydrate compoundsDegenerative nervous system diseasesAlzheimer's diseaseParkinson's disease

栾同晓、胡松、刘佳、王珊、毛拥军

展开 >

青岛大学附属医院老年医学科,青岛 266003

海洋糖类化合物 退行性神经系统疾病 阿尔茨海默病 帕金森病

2024

中华老年医学杂志
中华医学会

中华老年医学杂志

CSTPCD北大核心
影响因子:1.606
ISSN:0254-9026
年,卷(期):2024.43(12)